approved EB-2 (NIW)

Statistical Programmer

Bioinformatics · China · 2022-10-20

Processing Time
124 days
Decision Date
2022-10-20
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to develop bioinformatics pipelines for the detection of novel variants and genetic mutations associated with dementia. This work aims to identify new targets for the development of drugs to prevent, postpone, or treat the disease.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses dementia, a prevalent global disease, establishing its national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 12 years of experience, 8 publications, and 92 citations, demonstrating her expertise.

3 Waiver of Job Offer and Labor Certification Met

The essential nature of the work and its impact on U.S. health interests justify the waiver.

Why This Petition Was Approved

The petition was approved based on the petitioner's 8 peer-reviewed journal articles, 92 citations, and 12 years of professional experience. The case was supported by 2 expert recommendation letters and evidence of funding from the National Institutes of Health, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Dependent
Grants
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
New York 106 days 2023-01-28
The petitioner proposes to elucidate the genetic mechanisms underlying neurodegenerative diseases using expertise in biochemistry, genetics, and molecular biology. The work focuses on identifying new biological targets for the treatment of Alzheimer’s disease, Parkinson’s disease, and other dementias to provide insights into neuronal degeneration.

Others

Healthcare · China

WeGreened EB-2 (NIW) approved
California 31 days 2025-05-01
The petitioner proposes to develop and apply novel analytical approaches and machine learning models to uncover actionable insights for chronic disease prevention, management, and policy development. Her work specifically focuses on creating predictive tools for all-cause dementia to enable earlier clinical interventions and improve patient outcomes. The endeavor aims to alleviate the financial and operational burdens of long-term disease care on the U.S. healthcare system.

Psychiatrist

Healthcare · Iran

WeGreened EB-2 (NIW) rfe approved
United States 203 days 2025-08-05
The petitioner proposes to develop a streamlined system for prompt cognitive patient screening and immediate treatment initiation using bioinformatics tools. This work focuses on improving early detection and intervention for neurodegenerative conditions such as dementia and Alzheimer's disease.

Data Scientist

Biotechnology · China

WeGreened EB-2 (NIW) approved
603 days 2025-09-20
The petitioner proposes to develop computational and analytical tools to characterize the mechanisms of chronic and complex diseases. This work involves integrating large-scale biological data to accelerate the discovery of treatment strategies for neurodegenerative disorders and metabolic diseases.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-10-20.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 124 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist